Literature DB >> 24711149

The improvement in pelvic floor symptoms with weight loss in obese women does not correlate with the changes in pelvic anatomy.

Yavuz M Gozukara1, Gulcan Akalan, Ekrem C Tok, Hakan Aytan, Devrim Ertunc.   

Abstract

INTRODUCTION AND HYPOTHESIS: It has been suggested that weight reduction decreases the frequency of urinary incontinence (UI) episodes. However, it is not known if this improvement is associated with anatomical changes in the pelvis. The aim of this study was to investigate the effects of weight loss on UI episodes and pelvic floor anatomy.
METHODS: Three hundred seventy-eight overweight/obese women were randomly allocated either to behavioral weight loss or to structured education programs. The patients were evaluated by voiding diary, Pelvic Floor Distress Inventory (PFDI), and Pelvic Organ Prolapse Quantification (POP-Q) system at baseline and after 6 months.
RESULTS: The women in the intervention group had a mean weight loss of 9.4 %, whereas the weight in the control group remained almost the same (P < 0.001). While there were no change in stress and urge incontinence episodes in the control group, the mean number of stress incontinence episodes per 3-day diary dropped from 7.96 episodes to 3.11, and the mean number of urge incontinence episodes per 3-day diary dropped from 2.85 episodes to 1.08 in the study group (P < 0.05). Regarding the POP-Q system, only genital hiatus, perineal body, and Ap measurements were significantly lower in the weight loss group than in the control group after 6 months.
CONCLUSIONS: Weight reduction provides improvement in episodes of UI, decreases the incidence of drops of urine leakage, and increases quality of life related to pelvic floor symptoms. However, there are little to no changes in the parameters of the POP-Q system with weight reduction.

Entities:  

Mesh:

Year:  2014        PMID: 24711149     DOI: 10.1007/s00192-014-2368-z

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  30 in total

1.  The effect of pelvic organ prolapse on sexual function in a general cohort of women.

Authors:  Ekrem C Tok; Osman Yasa; Devrim Ertunc; Aysun Savas; Huseyin Durukan; Arzu Kanik
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

2.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  Descriptive epidemiology of urinary incontinence in 3,100 women age 30-59.

Authors:  L B Elving; A Foldspang; G W Lam; S Mommsen
Journal:  Scand J Urol Nephrol Suppl       Date:  1989

4.  Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group.

Authors:  J S Brown; D Grady; J G Ouslander; A R Herzog; R E Varner; S F Posner
Journal:  Obstet Gynecol       Date:  1999-07       Impact factor: 7.661

5.  Natural history of pelvic organ prolapse in postmenopausal women.

Authors:  Catherine S Bradley; M Bridget Zimmerman; Yingwei Qi; Ingrid E Nygaard
Journal:  Obstet Gynecol       Date:  2007-04       Impact factor: 7.661

6.  Urinary and anal incontinence in morbidly obese women considering weight loss surgery.

Authors:  Holly E Richter; Kathryn L Burgio; Ronald H Clements; Patricia S Goode; David T Redden; R Edward Varner
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

7.  Weight loss to treat urinary incontinence in overweight and obese women.

Authors:  Leslee L Subak; Rena Wing; Delia Smith West; Frank Franklin; Eric Vittinghoff; Jennifer M Creasman; Holly E Richter; Deborah Myers; Kathryn L Burgio; Amy A Gorin; Judith Macer; John W Kusek; Deborah Grady
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

Review 8.  Obesity and pelvic floor disorders: a systematic review.

Authors:  W Jerod Greer; Holly E Richter; Alfred A Bartolucci; Kathryn L Burgio
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

9.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

Review 10.  Obesity and urinary incontinence: epidemiology and clinical research update.

Authors:  Leslee L Subak; Holly E Richter; Steinar Hunskaar
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

View more
  6 in total

1.  Adverse Events Associated with Nonsurgical Treatments for Urinary Incontinence in Women: a Systematic Review.

Authors:  Ethan M Balk; Gaelen P Adam; Katherine Corsi; Amanda Mogul; Thomas A Trikalinos; Peter C Jeppson
Journal:  J Gen Intern Med       Date:  2019-05-06       Impact factor: 5.128

Review 2.  Heterogeneity in post-intervention prolapse and urinary outcome reporting: a one-year review of the International Urogynecology Journal.

Authors:  Dobrochna Globerman; Magali Robert
Journal:  Int Urogynecol J       Date:  2015-05-06       Impact factor: 2.894

Review 3.  The impact of bariatric surgery on urinary incontinence: a systematic review and meta-analysis.

Authors:  Bhawana Purwar; Rufus Cartwright; Geraldo Cavalcanti; Giuseppe Alessandro Digesu; Ruwan Fernando; Vik Khullar
Journal:  Int Urogynecol J       Date:  2019-04-26       Impact factor: 2.894

Review 4.  Prevention and management of pelvic organ prolapse.

Authors:  Ilias Giarenis; Dudley Robinson
Journal:  F1000Prime Rep       Date:  2014-09-04

Review 5.  Obesity and Pelvic Floor Disorders: A Review of the Literature.

Authors:  Andrzej Pomian; Wojciech Lisik; Maciej Kosieradzki; Ewa Barcz
Journal:  Med Sci Monit       Date:  2016-06-03

6.  A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain.

Authors:  Jameel Nazir; Zalmai Hakimi; Florent Guelfucci; Amine Khemiri; Francis Fatoye; Ana María Mora Blázquez; Marta Hernández González
Journal:  BMC Urol       Date:  2018-09-04       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.